S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Lawyers who successfully argued Musk pay package was illegal seek $5.6 billion in Tesla stock
Critical asset just had biggest fall on record (Ad)
Sports analytics may be outnumbered when it comes to artificial intelligence
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
Critical asset just had biggest fall on record (Ad)
Norway's hospitalized king gets a pacemaker in Malaysia after falling ill during vacation
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet
Critical asset just had biggest fall on record (Ad)
What to watch for as China's major political meeting of the year gets underway
South Korean doctors hold massive anti-government rally over medical school recruitment plan
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Lawyers who successfully argued Musk pay package was illegal seek $5.6 billion in Tesla stock
Critical asset just had biggest fall on record (Ad)
Sports analytics may be outnumbered when it comes to artificial intelligence
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
Critical asset just had biggest fall on record (Ad)
Norway's hospitalized king gets a pacemaker in Malaysia after falling ill during vacation
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet
Critical asset just had biggest fall on record (Ad)
What to watch for as China's major political meeting of the year gets underway
South Korean doctors hold massive anti-government rally over medical school recruitment plan
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Lawyers who successfully argued Musk pay package was illegal seek $5.6 billion in Tesla stock
Critical asset just had biggest fall on record (Ad)
Sports analytics may be outnumbered when it comes to artificial intelligence
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
Critical asset just had biggest fall on record (Ad)
Norway's hospitalized king gets a pacemaker in Malaysia after falling ill during vacation
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet
Critical asset just had biggest fall on record (Ad)
What to watch for as China's major political meeting of the year gets underway
South Korean doctors hold massive anti-government rally over medical school recruitment plan
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Lawyers who successfully argued Musk pay package was illegal seek $5.6 billion in Tesla stock
Critical asset just had biggest fall on record (Ad)
Sports analytics may be outnumbered when it comes to artificial intelligence
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
Critical asset just had biggest fall on record (Ad)
Norway's hospitalized king gets a pacemaker in Malaysia after falling ill during vacation
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet
Critical asset just had biggest fall on record (Ad)
What to watch for as China's major political meeting of the year gets underway
South Korean doctors hold massive anti-government rally over medical school recruitment plan
NASDAQ:RMTI

Rockwell Medical (RMTI) Stock Price, News & Analysis

$1.56
+0.15 (+10.64%)
(As of 03/1/2024 ET)
Today's Range
$1.36
$1.58
50-Day Range
$1.23
$1.95
52-Week Range
$1.16
$6.24
Volume
328,043 shs
Average Volume
168,004 shs
Market Capitalization
$44.44 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$8.00

Rockwell Medical MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
412.8% Upside
$8.00 Price Target
Short Interest
Healthy
2.48% of Float Sold Short
Dividend Strength
N/A
Sustainability
-2.35
Upright™ Environmental Score
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($0.40) to ($0.11) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.07 out of 5 stars

Medical Sector

191st out of 950 stocks

Pharmaceutical Preparations Industry

81st out of 423 stocks


RMTI stock logo

About Rockwell Medical Stock (NASDAQ:RMTI)

Rockwell Medical, Inc., together with its subsidiaries, operates as a healthcare company that engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. The company offers Triferic Dialysate and Triferic AVNU which are indicated to maintain hemoglobin in patients undergoing hemodialysis. It also manufactures, sells, delivers, and distributes hemodialysis concentrates, such as CitraPure citric acid concentrate, Dri-Sate dry acid concentrate, RenalPure liquid acid concentrate, dry acid concentrate mixer, and RenalPure and SteriLyte powder bicarbonate concentrate; and ancillary products, including cleaning agents, 6% bleach for disinfection, citric acid descale, filtration salts, and other supplies used by hemodialysis providers. The company's dialysis concentrate products are used to maintain human life by removing toxins and replacing critical nutrients in the dialysis patient's bloodstream. It is also developing other therapeutic product candidates for the treatment of hospitalized patients with acute heart failure; and home infusion therapy that allows patients to receive intravenous medications at home. Its target customers include medium and small sized dialysis chains and independent dialysis centers. Rockwell Medical, Inc. was incorporated in 1996 and is headquartered in Wixom, Michigan.

RMTI Stock Price History

RMTI Stock News Headlines

Critical asset just had biggest fall on record
What many consider America's critical financial asset suffers biggest fall on record. Expert says: "it's very bad for millions, protect yourself now."
Rockwell Medical Inc RMTI
Returning To Rockwell Medical: Buy At 65% Of Revenue
Critical asset just had biggest fall on record
What many consider America's critical financial asset suffers biggest fall on record. Expert says: "it's very bad for millions, protect yourself now."
Q3 2023 Rockwell Medical Inc Earnings Call
Rockwell Medical Announces Third Quarter 2023 Results
See More Headlines
Receive RMTI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Rockwell Medical and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/14/2023
Today
3/02/2024
Next Earnings (Confirmed)
3/21/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Health Care Equipment
Current Symbol
NASDAQ:RMTI
CUSIP
77437410
Employees
253
Year Founded
1995

Price Target and Rating

Average Stock Price Target
$8.00
High Stock Price Target
$11.00
Low Stock Price Target
$5.00
Potential Upside/Downside
+412.8%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

Net Income
$-18,680,000.00
Pretax Margin
-11.49%

Debt

Sales & Book Value

Annual Sales
$72.81 million
Book Value
$1.16 per share

Miscellaneous

Free Float
27,863,000
Market Cap
$44.44 million
Optionable
Optionable
Beta
1.16

Social Links

10 Best Stocks to Own in 2024 Cover

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio.

Get This Free Report

Key Executives

  • Dr. Mark Strobeck Ph.D. (Age 53)
    President, CEO & Director
    Comp: $643.41k
  • Ms. Megan C. Timmins (Age 51)
    Executive VP, Chief Legal Officer & Secretary
    Comp: $518.09k
  • Mr. Jesse Neri
    Senior Vice President of Finance
  • Mr. James A. McCarthy
    Senior Vice President of Business & Corporate Development
  • Mr. Timothy T. Chole
    Senior Vice President of Sales & Marketing
  • Ms. Heather R. Hunter
    Senior VP & Chief Corporate Affairs Officer
  • Mr. David J. Kull (Age 56)
    Secretary
  • Mr. Jason Finkelstein
    Investor Relations Representative














RMTI Stock Analysis - Frequently Asked Questions

Should I buy or sell Rockwell Medical stock right now?

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Rockwell Medical in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" RMTI shares.
View RMTI analyst ratings
or view top-rated stocks.

What is Rockwell Medical's stock price target for 2024?

2 Wall Street analysts have issued 12-month price objectives for Rockwell Medical's stock. Their RMTI share price targets range from $5.00 to $11.00. On average, they predict the company's stock price to reach $8.00 in the next year. This suggests a possible upside of 412.8% from the stock's current price.
View analysts price targets for RMTI
or view top-rated stocks among Wall Street analysts.

How have RMTI shares performed in 2024?

Rockwell Medical's stock was trading at $1.89 at the start of the year. Since then, RMTI shares have decreased by 17.5% and is now trading at $1.56.
View the best growth stocks for 2024 here
.

When is Rockwell Medical's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, March 21st 2024.
View our RMTI earnings forecast
.

How can I listen to Rockwell Medical's earnings call?

Rockwell Medical will be holding an earnings conference call on Thursday, March 21st at 8:00 AM Eastern. Interested parties can register for or listen to the call using this link.

How were Rockwell Medical's earnings last quarter?

Rockwell Medical, Inc. (NASDAQ:RMTI) posted its quarterly earnings data on Tuesday, November, 14th. The company reported ($0.07) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.12) by $0.05. The company earned $23.77 million during the quarter, compared to analyst estimates of $23.67 million. Rockwell Medical had a negative net margin of 11.49% and a negative trailing twelve-month return on equity of 64.39%. During the same quarter in the prior year, the business earned ($0.40) EPS.

When did Rockwell Medical's stock split?

Rockwell Medical shares reverse split on Friday, May 13th 2022. The 1-11 reverse split was announced on Friday, May 13th 2022. The number of shares owned by shareholders was adjusted after the closing bell on Friday, May 13th 2022. An investor that had 100 shares of stock prior to the reverse split would have 9 shares after the split.

What guidance has Rockwell Medical issued on next quarter's earnings?

Rockwell Medical updated its FY 2023 earnings guidance on Tuesday, January, 30th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $82.8 million-$83.8 million, compared to the consensus revenue estimate of $84.2 million.

What is Robert L. Chioini's approval rating as Rockwell Medical's CEO?

6 employees have rated Rockwell Medical Chief Executive Officer Robert L. Chioini on Glassdoor.com. Robert L. Chioini has an approval rating of 22% among the company's employees. This puts Robert L. Chioini in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Rockwell Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Rockwell Medical investors own include Immunomedics (IMMU), JinkoSolar (JKS), Seagen (SGEN), Geron (GERN), OPKO Health (OPK), Amarin (AMRN), Gilead Sciences (GILD), ImmunoGen (IMGN), Sorrento Therapeutics (SRNE) and VBI Vaccines (VBIV).

Who are Rockwell Medical's major shareholders?

Rockwell Medical's stock is owned by a variety of institutional and retail investors. Top institutional investors include Armistice Capital LLC (6.50%), Vanguard Group Inc. (3.77%), Perkins Capital Management Inc. (1.23%), Raymond James & Associates (0.78%), WealthTrust Axiom LLC (0.11%) and Citadel Advisors LLC (0.00%).
View institutional ownership trends
.

How do I buy shares of Rockwell Medical?

Shares of RMTI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:RMTI) was last updated on 3/3/2024 by MarketBeat.com Staff